Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

Saved in:
Bibliographic Details
Title: Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.
Authors: Foldi J; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Hogan G; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Johansen Taber K; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., LaBella M; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Sadler B; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Patel R; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Balic M; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Haslem D; Oncology Service Line, Intermountain Healthcare, Saint George, UT, USA., Mazo Canola M; Division of Hematology and Oncology, Mays Cancer Center, University of Texas at San Antonio, San Antonio, TX, USA., Peih-Ying Tsai J; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Cusick T; Department of Surgery, Ascension Via Christi Hospitals Wichita, Inc.., Wichita, KS, USA., Nathwani N; Carolina Blood and Cancer Care Associates, Lancaster, SC, USA., Naito Y; Department of Medical Oncology, Department of General Internal Medicine, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Funasaka C; Department of Medical Oncology, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Wong K; Department of Medical Oncology, Providence Saint Joseph's Medical Center, Burbank, CA, USA., Ham A; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Acevedo A; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Battey CJ; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Gould GM; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Muzzey D; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Jasper J; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.
Source: Future oncology (London, England) [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1985-1996. Date of Electronic Publication: 2026 Jun 21.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-8301
DOI:10.1080/14796694.2026.2690165